期刊文献+

HIF-1α抑制剂YC-1对肝癌细胞增殖凋亡的影响及机制 被引量:2

EFFECTS AND MECHANISM OF YC-1 ON THE CELL PROLIFERATION AND THE APOPTOSIS OF HUMAN HEPATOCELLULAR CARCINOMA CELL
下载PDF
导出
摘要 目的应用缺氧诱因因子-1 α(hypoxia inducible factor-1 α,HIF-1α)抑制剂YC-1处理SMMC-7721肝癌细胞,观察不同药物浓度对SMMC-7721肝癌细胞增殖的作用和对细胞周期及凋亡率的影响及其机制。方法肝癌细胞系SMMC-7721分对照组和实验组。对照组细胞常规培养,实验组细胞施加HIF-1α抑制剂YC-1干预,设浓度梯度和时间梯度。检测不同药物浓度、不同时间对SMMC-7721细胞增殖的作用及对细胞周期和凋亡率的影响。对bc1-2、bax、Survivin mRNA表达产物相对定量,并对SMMC-7721细胞胞浆bcl-2、bax、Survivin蛋白进行相对定量分析。结果①与对照组相比,各实验组OD值均有显著下降,细胞数量降低(P<0.05),且呈明显的时间-剂量依赖效应。②不同浓度YC-1处理细胞后,均可使各处理组G_0/G_1期细胞增多,S期细胞减少,且呈时间-剂量依赖效应(P<0.05)。③不同浓度YC-1处理细胞不同时间后,与对照组相比,各实验组bcl-2mRNA和Survivin mRNA表达均有显著下降(P<0.05),而bax mRNA无明显变化趋势(P>0.05)。④不同浓度YC-1处理细胞不同时间后,与对照组相比,各实验组bcl-2和Survivin的蛋白表达显著下降(P<0.05),bax蛋白表达显著增加(P<0.05)。结论 YC-1可以将SMMC-7721肝癌细胞株阻滞于G_0/G_1期,影响细胞周期进程,抑制细胞增殖,促进细胞凋亡。HIF-1α促进增殖抑制凋亡的机制是上调肝癌细胞Survivin和bcl-2的表达,下调bax的表达。HIF-1 α抑制剂的应用为肝癌的治疗提供了新的思路。 Objective To explore the effects and mechanism of YC - 1 on the cell proliferation and the apoptosis of human hepatocellular carcinoma cell line SMMC -7721. Methods SMMC -7721 cells were divided as control group and experiment group. The former were cultured with normal condition, the later were treated by YC - 1 with Various concentration and time. Changes of cell cycle and apoptosis rate after treated by YC - 1 with various concentration and time were detected. The expression of bcl-2,bax,Survivin mRNA level in cultured SMMC -7721 was evaluated by RT- PCR. The bcl- 2,bax, Survivin protein in cytoplasm was evaluated by western blot. Results ①After treated with YC - 1, the OD values of treated groups decreased compared with control group, and there was statistically significant difference between control group and every treatment group (P 〈 0.05 ). The inhibition of the proliferation of SMMC - 7721 cells by YC - 1 displayed a dose - and - time - dependent manner ( P 〈 0. 05). ②The distribution of cell cycle by flow cvtometrv indicates that after treated with YC -1,the number of cells in GO/G1 phase increased gradually, while the number of cells in S phase decreased grudually,which was in a dose - and - time - dependent manner. ③Following the increasing of the concentration of YC - 1, the expression of bcl - 2 mRNA and Survivin mRNA decreased gradually compared with control group. But there was no obvious change of the bax mRNA ( P 〉 0.05 ). ④Following the increasing of the concentration of YC - 1, expression of bcl - 2 protein and Survivin protein decreased gradually,butbax protein increased gradually. Conclusion The YC -1 can inhibit the proliferation and affect the cell cycle by inhibiting the G1 period of SMMC -7721 cell. The mechanisms were supposed to be that HIF - 1α up - regulates the expression of Survivin and bcl - 2 and down - regulates the expression of bax. The effects were in time - dependent pattern. The application of the HIF - 1α inhibitor offer a new way for the treatment of the HCC.
出处 《河北医科大学学报》 CAS 2011年第11期1268-1274,共7页 Journal of Hebei Medical University
关键词 肝肿瘤 细胞增殖 细胞凋亡 liver neoplasms cell proliferation apoptosis
  • 相关文献

参考文献6

二级参考文献59

  • 1徐宗全,陈孝平,张万广,李常海,李高鹏.Tet-on基因表达系统调控HIF-1α表达对肝癌细胞凋亡的影响[J].中华普通外科杂志,2006,21(11):769-772. 被引量:3
  • 2徐静,陈孝平,秦诚.Twist、HIF-1α及HBx在原发性肝癌表达及相关性研究[J].中国现代普通外科进展,2007,10(1):37-39. 被引量:5
  • 3Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J]. Nature, 1998,394(6692) :485-490.
  • 4Luo F, Liu X, Yan N, et al. Hypoxia-inducible transcription factor- 1 alpha promotes hypoxia-induced A549 apoptosls via a mechanism that involves the glycolysis pathway [J]. BMC Cancer, 2006,6:26.
  • 5Liu XH, Yu EZ, Li YY, et al. HIF-1 alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression [ J ]. J Cell Biochem, 2006,97 (4) :755-765.
  • 6Mizuno T, Nagao M, Yamada Y, et al. Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers [ J ]. Cancer Gene Ther, 2006,13(2) :131-140.
  • 7Yoshida D, Kim K, Noha M, et al. Anti-apoptotic action by hypoxia inducible factor 1-alpha in human pituitary adenoma cell line, HP- 75 in hypoxic condition [ J ]. J Neurooncol, 2006,78 (3) :217-225.
  • 8Zhu H, Bunn HF. Oxygen sensing and signaling: impact on the regulation of physiologically important genes [ J ]. Respir Physiol, 1999,115 (2) :239-247.
  • 9Peng XH, Karna P, Cao Z, et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-lalpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression [J]. J Biol Chem, 2006,281(36) :25903-25914.
  • 10Ko FN,Wu CC, Kuo SC,et al. YC -1, a novel activator of platelet guanylate cyclase [ J ]. Blood, 1994,84:4226 - 4233.

共引文献9

同被引文献33

  • 1徐韬,胡伟汉,高远红,姚金娥,夏云飞,王芳,蔡修宇.3-(5'羟甲基-2'呋喃基)-1苯甲基吲唑联合放疗治疗Lewis移植瘤小鼠的实验研究[J].肿瘤研究与临床,2008,20(2):76-79. 被引量:1
  • 2杜静,赵秋,谷华,滕晓丽,覃华,刘南植.缺氧条件下YC-1对人胰腺癌细胞VEGF和GPI基因的抑制效应[J].中华肿瘤杂志,2006,28(7):486-489. 被引量:5
  • 3FENG Y D,ZHU H, LING T S, et al. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Ecal09 cells [ J ]. Cell Biol Int,2011,35 ( 5 ) :491-497.
  • 4FALLAHIA F, KARAMI-TEHRANI F, SALAMI S, et al. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines[J]. FEBS J,2011,278(18) :3360-3369.
  • 5KONG J, KONG J, PAN B, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1cr./VEGFA [ J ]. PLoS One, 2012, 7 (5) : e37266.
  • 6LU D Y, TANG C H, LIOU H C, et al. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor- kappa B in microglia [ J ]. Br J Pharmacol, 2007,151 (3) :396-405.
  • 7ZHU H, FENG Y D, ZHANG J, et al. Inhibition of hypoxia inducible factor 1 c: expression suppresses the progression of esophageal squamous cell carcinoma[ J]. Cancer Biol Ther, 2011,11(11) :981-987.
  • 8WANG W,JIA W D,XU G L, et al. Antitumoral activity of rapamycin mediated through inhibition of HIF-lalpha and VEGF in hepatocellular carcinoma [ J ]. Dig Dis Sci, 2009, 54(10) :2128-2136.
  • 9CHOU L C, HUANG L J, HSU M H, et al. Synthesis of 1- benzyl-3-( 5-hydroxymethyl-2-furyl ) selenolo [ 3, 2-c ] pyrazolederivatives as new anticancer agents. [ J ]. Eur J Med Chem,2010,45 (4) : 1395-1402.
  • 10CHEN H J, HSU M H, HUANG L J, et al. Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI- H226 [ J ]. Biochemical Pharmacol, 2008,75 ( 2 ) : 360 - 368.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部